Kuzgunbay, BarisTurunc, Tahsin2019-09-112019-09-1120161309-0720http://www.bayrakol.org/en/2016/july2016/original-article/item/1328-percutaneous-nephrolithotomy-for-kidney-stones-in-patients-with-hematological-malignancyhttp://hdl.handle.net/11727/3880To define the alterations in the outcomes of percutaneous nephrolithotomy (PNL) operations for kidney stones in patients with history of hematological malignancy (HM). Material and Method: Between 2000 and 2013, 1700 adult patients underwent PNL for the treatment of kidney stones in our institution. Four of these patients had a history of HM and considered to be HM group (n=4). Ten elderly (>65 years) patients who had no history of operation, HM or any other co-morbide diseases were chosen as the control group (n=10). Surgical parameters, success rates, additional treatments and complications were evaluated. Results: Statistical analyses showed no significant differences between HM and control group according to stone area, operation time, fluoroscopy time, hospitalization time,Delta Hb, blood transfusion rates and INR values (p>0.05). Statistical analyses revealed no significant differences between HM and control groups according to the success rates (p=0.470). Statistical analyses revealed no significant difference between groups for additional treatment requirements (p=0.882). No major perioperative complication was seen in both of the groups. Discussion: The treatment of kidney stone disease by PNL in patients with hematological malignancy is feasible, safe and effective. However, close cooperation with the Hematology Department before the operation is mandatory.enginfo:eu-repo/semantics/openAccessPercutaneous NephrolithotomyKidney StonesHematological Malignancyarticle744254290003765671000012-s2.0-84962019849